The impact of COVID-19 on antipsychotic prescriptions for patients with schizophrenia in Australia

doi:10.1177/00048674211025716

The impact of COVID-19 on antipsychotic prescriptions for patients with schizophrenia in Australia

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	642-647
Number of pages	6
Journal	Australian and New Zealand Journal of Psychiatry
Volume	56
Issue number	6
DOIs	https://doi.org/10.1177/00048674211025716
Publication status	Published - Jun 2022
Externally published	Yes

ASJC Scopus Subject Areas

Psychiatry and Mental health

Keywords

COVID-19
Pharmaceutical Benefits Scheme
antipsychotic prescription volumes
schizophrenia

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/00048674211025716

Cite this

@article{327afd8f3df247e0b8ebadf86de1cf91,

title = "The impact of COVID-19 on antipsychotic prescriptions for patients with schizophrenia in Australia",

keywords = "COVID-19, Pharmaceutical Benefits Scheme, antipsychotic prescription volumes, schizophrenia",

note = "Publisher Copyright: {\textcopyright} The Royal Australian and New Zealand College of Psychiatrists 2021.",

year = "2022",

month = jun,

doi = "10.1177/00048674211025716",

language = "English",

volume = "56",

pages = "642--647",

journal = "Australian and New Zealand Journal of Psychiatry",

issn = "0004-8674",

publisher = "Informa Healthcare",

number = "6",

}

TY - JOUR

T1 - The impact of COVID-19 on antipsychotic prescriptions for patients with schizophrenia in Australia

N1 - Publisher Copyright: © The Royal Australian and New Zealand College of Psychiatrists 2021.

PY - 2022/6

Y1 - 2022/6

KW - COVID-19

KW - Pharmaceutical Benefits Scheme

KW - antipsychotic prescription volumes

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=85110220450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85110220450&partnerID=8YFLogxK

U2 - 10.1177/00048674211025716

DO - 10.1177/00048674211025716

M3 - Article

AN - SCOPUS:85110220450

SN - 0004-8674

VL - 56

SP - 642

EP - 647

JO - Australian and New Zealand Journal of Psychiatry

JF - Australian and New Zealand Journal of Psychiatry

IS - 6

ER -

The impact of COVID-19 on antipsychotic prescriptions for patients with schizophrenia in Australia

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this